Comments on: FDA Approves Labeling Change For VYVANSE CII To Efficacy At 13 Hours Postdose In Children With ADHD

Comments on: FDA Approves Labeling Change For VYVANSE CII To Efficacy At 13 Hours Postdose In Children With ADHD http://discusspharmacy.com/2009/06/fda-approves-labeling-change-for-vyvanse-cii-to-efficacy-at-13-hours-postdose-in-children-with-adhd/ Blog for discussing pharmacy drugs and new developments in pharmacy Sun, 01 Aug 2010 08:15:29 +0000 http://wordpress.org/?v=2.7.1 hourly 1